Niresh Maheshwari
Director/Board Member at Cubic Capital Advisors LLP
Profile
Niresh Maheshwari is an Independent Director at Unidrug Innovative Pharma Technologies Ltd.
He is also a Director at Cubic Capital Advisors LLP and a Member of The Institute of Chartered Accountants of India.
Previously, he served as an Independent Non-Executive Director at Sobhagya Mercantile Ltd.
from 2022 to 2024 and as the Chief Financial Officer at Uniinfo Telecom Services Ltd.
from 2018 to 2020.
He completed his undergraduate and graduate degrees from Devi Ahilya University.
Niresh Maheshwari active positions
| Companies | Position | Start |
|---|---|---|
| The Institute of Chartered Accountants of India | Corporate Officer/Principal | - |
Unidrug Innovative Pharma Technologies Ltd.
 Unidrug Innovative Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Unidrug Innovative Pharma Technologies Ltd. engages in the manufacture of active pharmaceutical ingredients and its intermediates. Its products include Allopurinol, Alprazolam, Disulfiram, Etamsylate, Mefenamic Acid, Nitazoxanide, Propanolol HCL, Tinidazole, Baclofen, Guaifenesin and Ornidazole. The company was founded on March 13, 1987 and is headquartered in Indore, India. | Director/Board Member | 2018-09-19 |
| Cubic Capital Advisors LLP | Director/Board Member | - |
Former positions of Niresh Maheshwari
| Companies | Position | End |
|---|---|---|
| SOBHAGYA MERCANTILE LIMITED | Director/Board Member | 2024-06-06 |
| UNIINFO TELECOM SERVICES LIMITED | Director of Finance/CFO | 2020-06-29 |
Training of Niresh Maheshwari
| Devi Ahilya University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| UNIINFO TELECOM SERVICES LIMITED | Communications |
| SOBHAGYA MERCANTILE LIMITED | Non-Energy Minerals |
| Private companies | 2 |
|---|---|
Unidrug Innovative Pharma Technologies Ltd.
Unidrug Innovative Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Unidrug Innovative Pharma Technologies Ltd. engages in the manufacture of active pharmaceutical ingredients and its intermediates. Its products include Allopurinol, Alprazolam, Disulfiram, Etamsylate, Mefenamic Acid, Nitazoxanide, Propanolol HCL, Tinidazole, Baclofen, Guaifenesin and Ornidazole. The company was founded on March 13, 1987 and is headquartered in Indore, India. | Health Technology |
| Cubic Capital Advisors LLP |
- Stock Market
- Insiders
- Niresh Maheshwari
